not losing weight on semaglutide should i switch to tirzepatide Switching From Semaglutide: What to Expect not losing weight on semaglutide

For Orange County patients, the appeal of Ozempic often comes down to practicality

The Core Benefits of Microdosing Liver and Cardiovascular Protection A 72-week trial found 40% of patients achieved resolution of fatty liver disease without worsening fibrosis. In animal models, GLP-1s suppress fat production in the liver and reduce inflammation. Tirzepatide at low doses showed particularly strong cardiovascular benefits, with meaningful improvements across multiple lipid markers linked to heart disease risk. Cholesterol storage forms increased far less with tirzepatide, and harmful lipids like ceramides showed minimal increase compared to placebo

Double-checking prevents errors that compound over weeks of dosing

GLP-1 peptide therapy refers to the use of naturally inspired compounds that mimic hormones your body already produces